Standards of care for #obesity once said judge first and offer medicines seldom.
Yesterday, the Obesity Association of @amdiabetesassn.bsky.social released new standards of care for #ObesityMedicines - endorsed by most every obesity organization in the U.S.
conscienhealth.org/2026/01/14/n...
Criminals are moving in on the opportunity for bogus #ObesityMedicines. Why? Health systems conspire to deny access to safe and effective medicines for the sake of their own bottom lines. Money talks and patients suffer all around.
HT: @thetimes.com
conscienhealth.org/2025/12/prof...
In yesterday's announcement of lower prices and expanded coverage for #ObesityMedicines in #Medicare, we have a lot to digest. Also, oral sema and orforglipron are on a fast track for approval.
From @elilillyandcompany.bsky.social and @novonordisk.bsky.social.
conscienhealth.org/2025/11/good...
In @theatlantic.com, economics professor Emily Oster says there’s a simple reason for opening up access to #ObesityMedicines for all. They will save many lives and improve many others.
conscienhealth.org/2025/10/from...
Yesterday, @obesitycanada.bsky.social took another leap forward with their second update to clinical guidance for #ObesityMedicines. In the background lurks some unresolved dissonance in clinical definitions for #obesity.
conscienhealth.org/2025/08/cana...
People of modest means who need #ObesityMedicines to prevent suffering and a premature death cannot get them. But tax-free #wellness sauna for people with a big bankroll? Step to the front of the line. #Disparities rule.
HT: @ronlieber.bsky.social @nytimes.com
conscienhealth.org/2025/07/a-ta...
Such a flood of #innovation in #ObesityMedicines this week at #ADA2025 that investors are struggling to follow the thread and remember that obesity is a chronic disease. It's a marathon, not a sprint.
conscienhealth.org/2025/06/look...
At #ADA2025 the treat of the day was a good look at intriguing results from two very promising new and unique #ObesityMedicines, #MariTide and #bimagrumab.
HT: @amgen.bsky.social @elilillyandcompany.bsky.social
conscienhealth.org/2025/06/ada2...
From @elilillyandcompany.bsky.social, @novonordisk.bsky.social, and a host of other companies, at #ADA2025 it feels a bit like a fire hose of new data on new #ObesityMedicines – including #orforglipron and #amycretin. The pipeline is full to overflowing.
conscienhealth.org/2025/06/ada2...
Patients are pawns in a #PriceNegotiation over #ObesityMedicines. Both pharma and health insurer have lost the thread of health that runs through the core of their businesses.
HT: @lauradavisson.bsky.social @flytehealth.bsky.social
conscienhealth.org/2025/05/are-...
Economists, politicians, and even CMS all seem to agree that the door for #ObesityMedicines into #Medicare and #Medicaid should not be closed.
conscienhealth.org/2025/04/no-t...
News came late yesterday that CMS is not yet ready to extend #Medicare coverage to #ObesityMedicines. This was a near miss, but we are confident it will come.
conscienhealth.org/2025/04/cms-...
In @jama.com Network Open Lauren Oshman et al provide data on the overwhelming support of older Americans for access to #ObesityMedicines through coverage by #Medicare.
conscienhealth.org/2025/03/olde...
Will the next generation of #ObesityMedicines, like #retatrutide, have an impact on #cancer. New research suggests it might.
conscienhealth.org/2025/03/an-e...
As the potency of #ObesityMedicines for #WeightLoss grows, @fda.gov and HCPs need to refocus on the right target for #ObesityCare. It's all about health gain, not just weight loss.
conscienhealth.org/2025/02/weig...
It’s official. @fda.gov yesterday declared that the #semaglutide shortage is over and now we wonder how quickly and completely the #compounding of #ObesityMedicines will vanish.
conscienhealth.org/2025/02/the-...
New polling just out from
@ObesityAdvocacy
and
@focaldataHQ
:
Broad, bipartisan support for the Trump administration taking action to cover #ObesityMedicines under #Medicare.
conscienhealth.org/2025/02/broa...
New polling just out from the Obesity Care Advocacy Network and Focaldata AI:
Broad, bipartisan support for the Trump administration taking action to cover #ObesityMedicines under #Medicare.
conscienhealth.org/2025/02/broa...
From the @apnews.com NORC Friday we learned that negative attitudes about #ObesityMedicines have melted away as people are finding better health and better lives with their judicious use. This is a radical shift in #PublicOpinion for sure.
conscienhealth.org/2025/02/the-...
Advocates worked hard to pass a law to guarantee #access to #ObesityMedicines in Connecticut. Now the state is flouting that law. One step forward, two steps back.
HT: @neilflochmd.bsky.social @mattlesser.bsky.social r
conscienhealth.org/2025/01/conn...
Some #PBMs are pretending they cover part of the cost of the #ObesityMedicines. But in fact, they’re charging a “copay” that exceeds the net price those PBMs typically pay for the drugs.
conscienhealth.org/2024/12/expl...
When #compounded #ObesityMedicines first started showing up, they seemed like a temporary, annoying distraction. Time has proved us wrong. News from Congress and @fda.gov makes us doubt they will fade away soon.
conscienhealth.org/2024/12/sign...
They did it. Word is out that the Biden administration is finally moving to open up #Medicare and #Medicaid for covering #ObesityMedicines. Yes, this is just a proposal, but it is a big step forward after many years of seeking this progress.
conscienhealth.org/2024/11/brea...
